Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GILENYA for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 256 adverse event reports in the FDA FAERS database where GILENYA was used for Relapsing-remitting multiple sclerosis.

Most Reported Side Effects for GILENYA

Side Effect Reports % Deaths Hosp.
Fatigue 208 12.4% 0 34
Multiple sclerosis relapse 161 9.6% 6 79
Headache 154 9.2% 0 34
Dizziness 119 7.1% 1 38
Central nervous system lesion 107 6.4% 4 30
Gait disturbance 93 5.6% 3 27
Hypoaesthesia 90 5.4% 1 23
Nausea 85 5.1% 0 24
Fall 84 5.0% 3 28
Vision blurred 81 4.8% 0 13
Muscular weakness 77 4.6% 2 28
Malaise 75 4.5% 2 32
Asthenia 74 4.4% 3 28
Pain 69 4.1% 2 22
Back pain 65 3.9% 0 15

Other Indications for GILENYA

Multiple sclerosis (1,114) Product used for unknown indication (18) Multiple sclerosis relapse (6) Off label use (6)

Other Drugs Used for Relapsing-remitting multiple sclerosis

OCRELIZUMAB (15,658) FINGOLIMOD (8,814) OFATUMUMAB (3,864) DIMETHYL (3,638) NATALIZUMAB (2,749) INTERFERON BETA-1A (2,058) GLATIRAMER (1,965) ALEMTUZUMAB (1,604) TERIFLUNOMIDE (1,320) RITUXIMAB (956)

Related Pages

GILENYA Full Profile All Relapsing-remitting multiple sclerosis Drugs GILENYA Demographics GILENYA Timeline